Bioplasma

The remedy was already in the patient.

A blood-component collection system that turns the patient’s own blood into a fibrin membrane (PRF) for chronic wounds.

Fibrin membrane (PRF)

The patient's own blood

Made in Brazil

About 1 hour

ANVISA registration

Class II

No. 82832389002

Medical device

The problem

A chronic wound is a wound that stopped closing.

A lesion that fails to progress toward healing in the expected time and stays open for weeks or months.

Examples

Diabetic foot ulcers, burns and traumatic injuries that do not heal.

Heavy routine

Constant dressing changes, staff time and frequent return visits.

Growing risk

Infection, hospitalization and, in severe cases, amputation.

The scale in Brazil

A public health problem, not just a clinical one.

Diabetes is behind a large share of non-healing wounds and preventable amputations in the country.

16.6 M

adults with diabetes in Brazil, 6th country in the world by cases

up to 1 in 4

people with diabetes will develop a foot ulcer

10,168

diabetes-related amputations in the SUS in 2022, about 28 per day

No. 1

cause of non-traumatic lower-limb amputation

Sources: IDF Diabetes Atlas 2025, via SBD · Brazilian Ministry of Health and SBD, via Agência Brasil (2023).

The answer

Tubo de coleta em laboratório (imagem ilustrativa)

The answer is in the patient's own blood.

PRF (Platelet-Rich Fibrin) is a concentrate obtained by centrifugation of blood alone, with no anticoagulant and no additives. Bioplasma turns this concentrate into a membrane ready to cover the wound.

Autologous

No donor

Natural

Nothing synthetic

Simple

No additives

How it works

From collection to membrane, in four steps.

About 1 hour in total

Everything the procedure needs comes in a sterile, standardized kit, designed for the routine of outpatient clinics, health units and the bedside.

Bioplasma

Step 01 · Collection

A blood draw just like a routine one.

Venipuncture and collection into tubes without anticoagulant, at the bedside or in the outpatient clinic, using the kit’s own materials.

  • Venous access: tourniquet on the arm and puncture with a butterfly needle (scalp vein set).
  • Closed system: blood flows through the flexible tubing and enters the collection tube through the red cap.
  • Straight to the centrifuge: with no anticoagulant, the tubes are centrifuged right after collection.
Bioplasma

Step 02 · Centrifugation

The blood separates into layers.

The spinning force arranges the blood components by density.

  • Balanced rotor: the tubes are placed symmetrically to balance the centrifuge.
  • Natural clot: with no anticoagulant, fibrin forms during the spin and traps the platelets.
  • Kit parameters: speed and time defined in the Bioplasma protocol.
Bioplasma

Step 03 · PRF clot

In the middle of the tube, the fibrin clot.

The fibrin is removed with forceps and separated from the red blood cells.

  • Top: plasma.
  • Middle: platelet-rich fibrin clot (PRF).
  • Bottom: red blood cells — the small red portion is cut off and discarded.
Bioplasma

Step 04 · Bioplasma device

One device, two fractions.

Bioplasma shapes the clot and separates what goes onto the wound.

  • Perforated plate: the clots are placed one by one and settle into a flat, even shape.
  • Flat fibrin membrane: ready on the plate to be applied directly to the wound.
  • Liquid fraction: drips through the holes, collects in the base and can be drained via the side tube.

Application

The patient's own matrix, placed where it was missing.

Wound preparation

Cleansing of the wound bed per the team's protocol.

Placement

Using forceps, the membranes are laid in strips, side by side, covering the entire area.

Dressing and follow-up

Secondary dressing and reassessments per the clinical protocol.

Bioplasma

Mechanism of action

Inside, fibrin is a mesh.

In the literature, the PRF matrix is described as a reservoir that gradually releases platelet growth factors (such as PDGF, TGF-β and VEGF).

The mesh acts as a scaffold over the wound.

The body's cells move in and get to work.

Over time, the mesh gives way to new tissue.

On top, the skin closes.

Real cases

Three patients, a single application each.

1 PRF session

Closure after 1 application

Diabetic foot

Age 52 · wound open for 3 months

28 days

Closure after 1 application

Burn

Age 82, hypertensive · 3 months

20 days

Closure after 1 application

Hand, 4th metacarpal

37-year-old athlete

7 days

Clinical reports from the treating clinicians · Individual results, not a guaranteed timeframe.

Where to use it

Wounds that won't close, from different causes.

Senhor caminhando em um parque (imagem ilustrativa)

Diabetic foot

Chronic ulcers in patients with diabetes, the main path to amputation.

Mãos dadas em sinal de cuidado (imagem ilustrativa)

Burns

Lesions that remain open, including in elderly patients with comorbidities.

Atleta na pista de corrida (imagem ilustrativa)

Traumatic injuries

Trauma wounds that need a matrix to close.

The indication for each case is determined by the clinical assessment of the responsible professional.

In practice

Simple to operate, ready for routine use.

Everything the procedure needs comes in a sterile, standardized kit.

Single use

Sterile, disposable kit

About 1 hour

From collection to application

Made in Brazil

Domestically manufactured

ANVISA Class II

Reg. 82832389002

Why it matters

Value for those who treat and those who manage healthcare.

For medical teams

For public health management

Regulatory compliance

Registration, quality and compliance.

Bioplasma is registered with ANVISA as a Class II device. For international distribution, Novatec works in accordance with the regulatory requirements that apply to medical devices in each market.

Brazil

ANVISA

Class II registration · No. 82832389002

European Union

CE marking

Medical Device Regulation (EU) 2017/745 — MDR

Azerbaijan

State registration

Medical devices above risk class I

Requirements apply according to the product’s risk classification in each market. The product is only imported once the applicable regulatory requirements are met.

Next steps

How to get started.

Demonstration

Technical presentation of the kit to your unit or health department team.

Pilot project

Supervised application in a group of patients, with each case recorded.

Scale-up

Team training and inclusion in the wound care protocol.

Médica atendendo paciente em consultório (imagem ilustrativa)

Talk to Novatec

Book a technical demonstration of Bioplasma for your team or health department.

    Or reach us directly:

    Bioplasma

    The remedy was already in the patient.